Full Text View
Tabular View
No Study Results Posted
Related Studies
The Joint Asia Diabetes Evaluation (JADE) Program in Hong Kong Community (JADE1)
This study is ongoing, but not recruiting participants.
Study NCT00711152   Information provided by Chinese University of Hong Kong
First Received: July 7, 2008   Last Updated: January 28, 2009   History of Changes

July 7, 2008
January 28, 2009
March 2008
November 2009   (final data collection date for primary outcome measure)
Change in glycated hemoglobin level [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00711152 on ClinicalTrials.gov Archive Site
effectiveness and user-acceptability of the internet on-line and computer record system (JADE) [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
 
The Joint Asia Diabetes Evaluation (JADE) Program in Hong Kong Community
An Implementation Project to Evaluate the Effectiveness and Acceptability of the Joint Asia Diabetes Evaluation (JADE) Program in Hong Kong Chinese Type 2 Diabetic Patients In a Community Setting
  1. To recruit 600 type 2 diabetic patients managed in a community setting.
  2. To enrol into the Joint Asia Diabetes Evaluation (JADE) Program.
  3. After the comprehensive assessment at enrolment, half of the patients will be managed according to the JADE protocol implemented with assistance of a clinic nurse. The other half of the patients will be managed in the usual manner.
  4. At the end of 1 year, all patients will undergo repeat comprehensive assessments for comparison of attainment of treatment targets.
  5. The acceptability of the JADE Program by patients and clinic staff will also be evaluated.

Several lines of evidence support protocol-driven care using a multidisciplinary approach with special focus on periodic assessments, reinforcement of compliance and attainment of treatment targets improves risk factor control and reduces morbidity and mortality in people with diabetes mellitus The Joint Asia Diabetes Evaluation (JADE) Program is an innovative project using state of the art information technology with internet on-line system to enable doctors, nurses and other medical personnel to manage people with diabetes. It provides a virtual platform to facilitate implementation of evidence-based clinical protocols and to collect, manage and analyse data to track performance for quality assurance and improvement purposes. The JADE Program incorporates validated risk equations developed by the CUHK Diabetes Care & Research Group to stratify patients into various risk clusters for recommendation into different care protocols. This information can be relayed to people with diabetes in an interactive manner, in the form of charts and time trends, to motivate changes in behaviour and to attain treatment targets.

In this implementation project, we aim to recruit 600 type 2 diabetic patients managed in a community setting. With written informed consent, these patients will be invited to enrol into the JADE Program. After the comprehensive assessment at enrolment, half of the patients will be managed according to the JADE protocol implemented with assistance of a clinic nurse. The other half of the patients will be managed in the usual manner. At the end of 1 year, all patients will undergo repeat comprehensive assessments for comparison of attainment of treatment targets The acceptability of the JADE Program by patients and clinic staff will also be evaluated.

Phase IV
Interventional
Other, Randomized, Open Label, Parallel Assignment, Efficacy Study
Type 2 Diabetes Mellitus
Other: Protocol-driven care under JADE Program
  • Active Comparator: Study doctors are using JADE Program to enhance implementation of protocol-driven care to the enrolled diabetic patients
  • Other: Usual Care: This arm of patients is managed as usual, without the help of JADE Program
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
600
November 2011
November 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Patients with confirmed diagnosis of type 2 diabetes, aged 18 years or above, attending the Hospital Authority Ma On Shan Family Medicine Clinic in New Territory East Cluster
  2. Type 2 diabetes is defined as follows:

    • Known history of type 2 diabetes with treatment such as lifestyle modification and/or anti-diabetic drugs for 6 months or more.
    • WHO diagnostic criteria (2 abnormal results in asymptomatic subjects or 1 abnormal result in subjects with symptoms or diabetic complications:

      • Fasting plasma glucose (PG) 7.0 mmol/L or above
      • Random PG 11.1 mmol/L or above
      • Post 75 g oral glucose tolerance test (OGTT) 2-hour PG 11.1 mmol/L or above

Exclusion Criteria:

Type 1 diabetes defined as history of ketosis [acute symptoms with heavy ketonuria (>3+) or ketoacidosis] or heavy ketonuria (>3+) or continuous requirement of insulin treatment within one year of diagnosis and thereafter.

  1. Patients with terminal malignancy or other life-threatening diseases with less than 6-month expected survival
  2. Telephone contact not available
  3. Patients with a mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
China
 
NCT00711152
Juliana Chan, Chinese University of Hong Kong
CRE-2007-339
Chinese University of Hong Kong
 
 
Chinese University of Hong Kong
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP